Real-time enrollment status for this common warts clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 8:12 PM UTC
| NCT Number | NCT07246590 |
| Recruiting Status | Recruiting |
| Condition | Common Warts |
| Phase | PHASE3 |
| Target Enrollment | 300 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Verrica Pharmaceuticals Inc. |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of August 30, 2026: Clinical trial NCT07246590 is currently recruiting participants. This phase3 study for common warts is actively seeking new participants at 6 locations across the United States. The study is sponsored by Verrica Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07246590 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07246590 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.